Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Frontiers in Immunology|February 17, 2022
Targeting Tryptophan Catabolism in Cancer Immunotherapy Era: Challenges and PerspectivesFlorent Peyraud, Jean-Philippe Guegan, Dominique Bodet, et al.Cancer Research Communications|October 20, 2023
Antitumor Effects of PRMT5 Inhibition in SarcomasStéphanie Verbeke, Aurélien Bourdon, Jean-Philippe Guegan, et al.Experimental Hematology & Oncology|December 6, 2022
Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancerSophie Cousin, Maud Toulmonde, Michèle Kind, et al.Med (New York, N.Y.)|January 11, 2025
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedsideFlorent Peyraud, Jean-Philippe Guegan, Lucile Vanhersecke, et al.Journal of Cellular Physiology|March 26, 2011
The complexity of ERK1 and ERK2 MAPKs in multiple hepatocyte fate responsesChristophe Frémin, Frédéric Ezan, Jean-Philippe Guegan, et al.Journal of Hematology & Oncology|October 22, 2022
Randomized phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced soft-tissue sarcomaMaud Toulmonde, Sophie Cousin, Michèle Kind, et al.Biomarker Research|January 7, 2024
Deciphering the correlation between metabolic activity through 18F-FDG-PET/CT and immune landscape in soft-tissue sarcomas: an insight from the NEOSARCOMICS studyAmandine Crombé, Frédéric Bertolo, Lucile Vanhersecke, et al.Journal of Hematology & Oncology|October 24, 2024
Predictive value of tumor microenvironment on pathologic response to neoadjuvant chemotherapy in patients with undifferentiated pleomorphic sarcomasJean Philippe Guegan, Nathan El Ghazzi, Julien Vibert, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2023
Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung CancerAlban Bessede, Florent Peyraud, Sylvestre Le Moulec, et al.Molecular Cancer|February 20, 2024
Reshaping the tumor microenvironment of cold soft-tissue sarcomas with oncolytic viral therapy: a phase 2 trial of intratumoral JX-594 combined with avelumab and low-dose cyclophosphamideMaud Toulmonde, Jean-Philippe Guegan, Mariella Spalato-Ceruso, et al.Pageof 2